Bio-Rad launches vericheck ddPCR replication competent lentivirus and replication competent AAV kits for cell and gene therapy production

A Mary­land biotech led by an Army vet­er­an and for­mer West Point pro­fes­sor has raised an ad­di­tion­al $26 mil­lion to move its tar­get­ed ther­a­peu­tics plat­form

The use of completion axillary lymph node dissection (cALND) to determine the need for adjuvant abemaciclib (Verzenio) among women with luminal estrogen receptor (ER)-positive, HER2-negative